Brainstorm Cell Therapeutics Inc. (BCLI) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 184K | 307K | 508K | 1.51M | 2.33M | 385K | 364K | 3.82M | 1.26M | 1.9M | 1.54M | 1.21M |
| Cash & Short-Term Investments | 15K | 29K | 5K | 824K | 1.64M | 187K | 168K | 3.47M | 779K | 1.3M | 1.42M | 748K |
| Cash Only | 15K | 29K | 5K | 824K | 1.64M | 187K | 168K | 3.47M | 779K | 1.3M | 1.22M | 546K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 196K | 202K |
| Accounts Receivable | 122K | 86K | 80K | 106K | 67K | 63K | 0 | 33K | 26K | 51K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | 13.68 | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 47K | 192K | 423K | 585K | 621K | 135K | 40K | 171K | 169K | 23K | 66K | 93K |
| Total Non-Current Assets | 387K | 408K | 872K | 1.05M | 1.24M | 1.45M | 1.66M | 1.87M | 2.09M | 2.31M | 4.14M | 4.53M |
| Property, Plant & Equipment | 355K | 443K | 617K | 826K | 1.03M | 1.24M | 1.46M | 1.67M | 1.89M | 2.1M | 4.12M | 4.51M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | 0.11x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 0 | 0 |
| Long-Term Investments | 191K | 247K | 231K | 0 | 182K | 184K | 0 | 179K | 182K | 185K | 0 | 0 |
| Other Non-Current Assets | -159K | -282K | 24K | 225K | 22K | 22K | 203K | 20K | 20K | 19K | 21K | 22K |
| Total Assets | 571K | 715K | 1.38M | 2.57M | 3.57M | 1.83M | 2.02M | 5.68M | 3.35M | 4.21M | 5.68M | 5.75M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | 0.07x | - | - |
| Asset Growth % | -84.01% | -60.97% | -31.85% | -54.85% | 6.66% | -56.46% | -64.36% | -1.11% | -57.47% | -50.21% | -57.13% | -69.69% |
| Total Current Liabilities | 11.76M | 11.01M | 9.02M | 8.53M | 10.9M | 8.98M | 7.08M | 7.69M | 6.83M | 7.8M | 6.32M | 7.69M |
| Accounts Payable | 7.32M | 7.07M | 6.42M | 6M | 6.8M | 6.08M | 4.6M | 5.34M | 4.69M | 4.95M | 3.93M | 5.19M |
| Days Payables Outstanding | 17.49K | 12.93K | - | - | 11.14K | 9.27K | 7.75K | 7.13K | 6.86K | 6.19K | 6.45K | - |
| Short-Term Debt | 1.49M | 1.18M | 377K | 101K | 1.2M | 0 | 0 | 566K | 588K | 603K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.96M | 1.8M | 2.23M | 1.68M | 1.92M | 2.35M | 1.04M | 1.78M | 1.55M | 2.24M | 1.03M | 1.06M |
| Current Ratio | 0.02x | 0.03x | 0.06x | 0.18x | 0.21x | 0.04x | 0.05x | 0.50x | 0.18x | 0.24x | 0.24x | 0.16x |
| Quick Ratio | 0.02x | 0.03x | 0.06x | 0.18x | 0.21x | 0.04x | 0.05x | 0.50x | 0.18x | 0.24x | 0.24x | 0.16x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 208K | 50K | 95K | 127K | 618K | 1M | 1.52M | 2.07M | 1.27M | 1.94M | 1.94M |
| Long-Term Debt | 0 | 208K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 50K | 95K | 127K | 171K | 271K | 396K | 533K | 672K | 1.58M | 1.94M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 447K | 729K | 1.12M | 1.53M | 594K | 358K | 0 |
| Total Liabilities | 11.76M | 11.01M | 9.07M | 8.62M | 11.03M | 9.6M | 8.08M | 9.21M | 8.9M | 9.07M | 8.26M | 9.63M |
| Total Debt | 1.49M | 1.18M | 427K | 577K | 1.77M | 720K | 841K | 962K | 1.12M | 1.27M | 2.89M | 3.29M |
| Net Debt | 1.47M | 179K | 422K | -247K | 126K | 533K | 673K | -2.51M | 342K | -25K | 1.67M | 2.75M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -25.26x | -6.80x | - | -7.80x | - | -48.32x | -56.44x | - | - | -60.63x | -49.88x | - |
| Total Equity | -11.19M | -10.29M | -7.69M | -6.06M | -7.46M | -7.76M | -6.06M | -3.53M | -5.55M | -4.86M | -2.58M | -3.88M |
| Equity Growth % | -50.1% | -32.56% | -27.01% | -71.73% | -34.36% | -59.82% | -134.59% | 9.14% | -14.67% | -61.13% | -286.02% | -149.45% |
| Book Value per Share | -1.01 | -1.11 | -0.70 | -0.70 | -1.18 | -1.36 | -1.14 | -0.74 | -1.29 | -1.44 | -0.88 | -1.47 |
| Total Shareholders' Equity | -11.01M | -10.29M | -7.69M | -6.06M | -7.46M | -7.76M | -6.06M | -3.53M | -5.55M | -4.86M | -2.58M | -3.88M |
| Common Stock | 16K | 16K | 16K | 16K | 15K | 14K | 14K | 14K | 13K | 13K | 12K | 12K |
| Retained Earnings | -239.07M | -236.94M | -234.51M | -232.4M | -229.5M | -226.64M | -223.66M | -220.96M | -218.41M | -215.01M | -209.44M | -208.21M |
| Treasury Stock | -116K | -116K | -116K | -116K | -116K | -116K | -116K | -116K | -116K | -116K | -116K | -116K |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |